StockData
Oric Pharmaceuticals, Inc. logo

Oric Pharmaceuticals, Inc. (ORIC) stock

ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$8.00+0.48 (+6.38%)

Close on Nov 17, 2026Market cap $829.22MP/E –Yield –

Oric Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Oric Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$111.64M. For fiscal 2025 it was -$110.97M. The highest annual figure on record is -$20.68M in fiscal 2018.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$110.97M–
FY2024Dec 31, 2024-$112.66M–
FY2023Dec 31, 2023-$85.69M–
FY2022Dec 31, 2022-$75.14M–
FY2021Dec 31, 2021-$59.54M–
FY2020Dec 31, 2020-$45.27M–
FY2019Dec 31, 2019-$23.53M–
FY2018Dec 31, 2018-$20.68M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$31.61M–
Q1 FY2026Mar 31, 2026-$32.44M–
Q4 FY2025Dec 31, 2025-$22.48M–
Q3 FY2025Sep 30, 2025-$25.11M–
Q2 FY2025Jun 30, 2025-$30.84M–
Q1 FY2025Mar 31, 2025-$32.53M–
Q4 FY2024Dec 31, 2024-$28.05M–
Q3 FY2024Sep 30, 2024-$28.80M–
Q2 FY2024Jun 30, 2024-$25.63M–
Q1 FY2024Mar 31, 2024-$30.19M–
Q4 FY2023Dec 31, 2023-$24.27M–
Q3 FY2023Sep 30, 2023-$19.65M–
Q2 FY2023Jun 30, 2023-$21.15M–
Q1 FY2023Mar 31, 2023-$20.63M–
Q4 FY2022Dec 31, 2022-$15.33M–
Q3 FY2022Sep 30, 2022-$19.32M–
Q2 FY2022Jun 30, 2022-$17.78M–
Q1 FY2022Mar 31, 2022-$22.72M–
Q4 FY2021Dec 31, 2021-$16.28M–
Q3 FY2021Sep 30, 2021-$12.14M–
Q2 FY2021Jun 30, 2021-$16.21M–
Q1 FY2021Mar 31, 2021-$14.90M–
Q4 FY2020Dec 31, 2020-$17.83M–
Q3 FY2020Sep 30, 2020-$9.58M–
Q2 FY2020Jun 30, 2020-$9.58M–
Q1 FY2020Mar 31, 2020-$8.28M–
Q4 FY2019Dec 31, 2019-$7.15M–
Q3 FY2019Sep 30, 2019-$5.36M–
Q2 FY2019Jun 30, 2019-$5.49M–
Q1 FY2019Mar 31, 2019-$5.53M–

More Oric Pharmaceuticals figures

See a number that looks wrong?